+ND Capital Fund (f.k.a. NanoDimension) | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/+ND Capital Fund (f.k.a. NanoDimension)/Activity

+ND Capital Fund (f.k.a. NanoDimension) Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

5 investments· MAY 2025 – APR 2026Show all

Investment

Participated in Lightcast's $27M Series C financing, led by ARCH Venture Partners, to support commercial release of the Envisia single-cell functional analysis platform.

Lightcast Bio

Lightcast Bio +ND Capital Fund (f.k.a. NanoDimension)

businesswire.comAPR 14, 2026

APR 14, 2026

Investment

Participated in SPARK Microsystems' Series B-II financing of $12.37M with co-investors Cycle Capital, Export Development Canada, Idealist Capital, and Real Ventures.

Spark Microsystems

Spark Microsystems +ND Capital Fund (f.k.a. NanoDimension)

cbinsights.comMAR 2026

MAR 2026

Investment

Participated in Syndex Bio's $15.5M seed financing led by ARCH Venture Partners.

Syndex Bio

Syndex Bio +ND Capital Fund (f.k.a. NanoDimension)

syndex.bioFEB 23, 2026

FEB 23, 2026

Investment

Led investment in Dragon Vascular, a vascular medical device company, with $18.9M funding.

Dragon Vascular

Dragon Vascular +ND Capital Fund (f.k.a. NanoDimension)

cbinsights.comNOV 2025

NOV 2025

Investment

Participated in HAYA Therapeutics' $65M Series A for precision RNA-guided medicines.

Hayat Biotech

Hayat Biotech +ND Capital Fund (f.k.a. NanoDimension)

hayatx.comMAY 8, 2025

MAY 8, 2025

Exit

Portfolio company Inscripta merged with Manus Bio.

Inscripta

Inscripta +ND Capital Fund (f.k.a. NanoDimension)

cbinsights.comAPR 16, 2025

APR 16, 2025